Speak to your health care provider before stopping GLP1-RAs to discuss when to stop and how to manage your condition
Semaglutide is a prescription medication requiring physician evaluation
10.3724/abbs.2024150 Summary Keywords atherosclerosis, biomarkers, cardiometabolic disease, endothelial dysfunction, GLP-1RA, macrovascular complications, oxidized LDL (oxLDL), type 2 diabetes Citation Al-Taweel R and Malki A (2026) Role of glucagon-like peptide-1 receptor agonists in type 2 diabetes-associated atherosclerosis: from vascular mechanism to omics-based biomarkers and imaging
The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain
50% of kids are overweight or obese, and 33% are pre-diabetic
Most of the animal studies suggest that, after central or peripheral administration of GLP-1RA decreases acute food and water intake, as well as minimizes the blood glucose level and the BW gain [Table 1]
